cagrilintide news 2025 is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination New in the August 14,

Repeat this until your cat is tolerant to biting and stays focused on food

For medical use under professional supervision

For the latest on the peptide reviews and what they mean: Sources and further reading FDA 503A Bulk Drug Substances list and Federal Register notice (April 2026)

So the honest answer is: it's promising in animals and unproven in people

Peptides (TB-500, GHK-Cu, and Ipamorelin) target narrower recovery pathways, making direct comparisons useful for understanding the scope of each compound's preclinical evidence

It is often chosen by individuals who prioritize restorative sleep, stress resilience, or recovery as part of their longevity and wellness goals